Enhanced bactericidal effect of ceftriaxone drug encapsulated in nanostructured lipid carrier against gram-negative Escherichia coli bacteria: drug formulation, optimization, and cell culture study

MLA

Sahar Ebrahimi, et al. “Enhanced Bactericidal Effect of Ceftriaxone Drug Encapsulated in Nanostructured Lipid Carrier against Gram-Negative Escherichia Coli Bacteria: Drug Formulation, Optimization, and Cell Culture Study.” Antimicrobial Resistance and Infection Control, vol. 9, no. 1, Feb. 2020, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s13756-020-0690-4.

APA

Sahar Ebrahimi, Nafiseh Farhadian, Mohammad Karimi, & Mohsen Ebrahimi. (2020). Enhanced bactericidal effect of ceftriaxone drug encapsulated in nanostructured lipid carrier against gram-negative Escherichia coli bacteria: drug formulation, optimization, and cell culture study. Antimicrobial Resistance and Infection Control, 9(1), 1–12. https://doi.org/10.1186/s13756-020-0690-4

Chicago

Sahar Ebrahimi, Nafiseh Farhadian, Mohammad Karimi, and Mohsen Ebrahimi. 2020. “Enhanced Bactericidal Effect of Ceftriaxone Drug Encapsulated in Nanostructured Lipid Carrier against Gram-Negative Escherichia Coli Bacteria: Drug Formulation, Optimization, and Cell Culture Study.” Antimicrobial Resistance and Infection Control 9 (1): 1–12. doi:10.1186/s13756-020-0690-4.